Guide: WHO R&D Good Participatory Practice for COVID-19 clinical trials: a toolbox
by Mesh Editorial TeamThis toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.
Project Report: “Nothing about us without us”: How families affected by Zika are claiming back control
by Wellcome TrustEvaluation report from the Wellcome Trust's Sciart funding programme
Project Report: Going Viral: The Mother of all pandemics Podcast
by Mesh Editorial Team, Dr Mark Honigsbaum & Hannah MawdsleyLiterature: The Legacy of Zika in Brazil: Women, Needs and Rights
by Debora Diniz, Mesh Editorial TeamEvent: Showcase 2019 - International Society of Neglected Tropical Diseases Festival
by Mesh Editorial TeamRepository: Ebola Response Anthropology Platform
by Mesh Editorial TeamVideo: Association of Public Health Laboratories: Fighting Emerging Infectious Diseases
by Mesh Editorial TeamEvent: The International Society for Neglected Tropical Diseases Festival
by Mesh Editorial TeamLiterature: From ‘Trial Community’ to ‘Experimental Publics’: How Clinical Research Shapes Public Participation
by C. Montgomery & R. Pool, Mesh Editorial TeamThis article argues for a conceptual shift away from the static, singular term ‘trial community’ towards ‘experimental publics’. The authors observe that the term ‘community’ is often employed uncritically and assumes that ‘communities’ pre-exist research; that they are timeless and undifferentiated wholes. ‘Experimental publics’, by contrast, are dynamic, multiple, and impermanent in nature.